Latest Developments in Global Blood Lancet Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Blood Lancet Market

  • Medical Devices
  • Nov 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In May 2023, Abbott Laboratories revealed its development of the FreeStyle LibreLink, a non-invasive blood glucose monitoring device. The system uses an arm-mounted sensor to provide continuous 24/7 glucose tracking, ensuring convenience and accuracy. Despite its non-invasive approach, the device will require calibration with a lancet, maintaining the relevance of blood lancets in glucose monitoring
  • In March 2023, Astellas Pharma Inc. partnered with Roche Diabetes Care Japan to market the Accu-Chek Guide Me system, a high-accuracy blood glucose monitoring device integrated with BlueStar technology. This collaboration highlights the increasing demand for precise and user-friendly blood testing solutions. As an essential part of blood glucose monitoring, the partnership indirectly supports the growth of the blood lancet market
  • In September 2022, Tasso secured 510(k) clearance for its blood lancet, enabling it to address the growing demand for remote testing solutions. The Tasso+ device allows users to collect blood samples at home by simply placing the device on their arm and pressing a button to release the lancet. This innovation enhances convenience and accessibility for individuals requiring regular blood testing
  • In February 2022, Vault Health, a healthcare provider specializing in virtual care, partnered with Tasso, Inc., a leader in clinical-grade blood collection technology. This collaboration integrates Tasso’s innovative products and logistics into Vault’s turnkey services, enhancing convenience for users. The partnership aims to provide Vault customers with an improved, virtually painless blood sample collection experience, aligning with the growing demand for accessible and user-friendly healthcare solutions
  • In June 2021, Greiner Bio-One launched the MiniCollect PIXIE Heel Incision Safety Lancet, designed specifically for neonatal and pediatric heel incisions. This innovation meets the need for safe and efficient blood collection in sensitive care settings. By addressing this niche, Greiner Bio-One supports the growth of the blood lancet market, offering healthcare providers reliable tools for specialized procedures